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SUMMARY 
Background 
Magnetic resonance imaging (MRI) is a standard diagnostic procedure for evaluation of 
prostate cancer (PCa) and good image quality is essential. This could potentially be improved 
by adding three-dimensional T2 weighted imaging (3D-T2WI) to the standard protocol as it 
enables reconstruction of images in any given plane, potentially allowing us to better 
demonstrate the tumour/capsular interface. Independent of scanner parameters, patient factors 
such as bowel peristalsis and rectal distension by gas/stool can also affect image quality. The 
Prostate Imaging-Reporting and Data System (PI-RADS) guidelines acknowledge that there is 
currently lack of evidence in both areas and therefore no direct recommendation on patient 
preparation is given.  
Purpose 
To compare 3D-T2WI with conventional 2D-T2WI in assessment of local staging of PCa. We 
also examined the effect of anti-peristaltic agent hyoscine butylbromide (HBB) and rectal 
distension on the quality of anatomical and functional MR imaging of prostate. 
Patients and methods 
All studies were performed at 3T MRI scanner using PI-RADS recommended protocol 
including T2 weighted imaging (T2W), T1 weighted imaging (T1WI), diffusion weighted 
imaging (DWI) with maximum b-value at 2000s/mm2, apparent diffusion coefficient (ADC) 
maps and dynamic contrast enhanced (DCE) images. 
The first study included 75 patients undergoing MRI before radical prostatectomy. PI-RADS 
≥4 lesions were assessed for extracapsular extension (ECE) on 2D-T2W images using a 5-point 
Likert scale and the length of tumour prostatic capsular contact. A second read using additional 
3D-T2W images and reformats evaluated ECE and the maximal 3D capsular contact length 
and surface.  
The second study included 87 patients receiving 20 mg HBB prior to scanning (HBB group) 
and 86 patients who did not (non-HBB group). Two radiologists evaluated image quality of 
T2WI, DWI and ADC maps, using a 5-point Likert scale. DWI was further assessed for 
distortion and artefact, and T2WI for the presence of motion artefact or blurring. DCE image 
quality was assessed by recording the number of corrupt data points from the curve. 
In the third study, images of 173 patients were evaluated by two radiologists. Rectal volumes 
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were calculated and a subjective assessment of rectal distension was made using a 5-point 
Likert scale (1 = no stool/gas, 5 = large amount of stool/gas). DWI was scored for image 
quality, distortion and artefact. T2W images were evaluated for image sharpness and the 
presence of motion artefact. The stability of the DCE was assessed as in the second study. 
Results 
In the first study a total of 106 lesions were analysed for the presence of ECE. ECE was present 
in 54% of lesions with PI-RADS score of  4 and in 64% of all patients. ECE was reported as 
focal in 28% and established in 72%. In terms of subjective reads, sensitivity and specificity 
for 3D-T2 was 75.4% versus 64.9% for conventional 2D-T2 (p = 0.06), respectively and 83.7% 
versus 85.7% (p = 0.71) for conventional 2D-T2, respectively. 3D-T2 reads showed a 
significantly higher mean Likert score of 3.7 ± 1.4 versus 3.3 ± 1.4 (p < 0.01) in ECE positive 
lesions and non-significantly lower Likert score for ECE negative lesions with average score 
of 1.5 ± 1 versus 1.6 ± 0.9 (p = 0.27) as compared to 2D-T2. 3D-contact assessment had 
significantly higher sensitivity (73.7%) than 2D-contact (59.6%, p = 0.03), whilst maintaining 
the same specificity of 87.8% (p = 1). 3D-surface area evaluation increased sensitivity from 
59.6% to 82.5% (p < 0.01) but this was associated with a loss of specificity from 87.8% to 
71.4% (p < 0.01). High grade group (HGG) tumours showed significantly higher ECE 
prevalence (88%) than low grade group (LGG) at 44%, p < 0.01. In addition, in HGG a PPV 
of 90.9% was achieved at ≥ 5 mm, conversely for LGG, a PPV of 90.4% was achieved at a cut-
off at ≥ 12.5 mm. 
The second study showed significantly higher T2W image quality in the HBB group than in 
the non-HBB group (3.6 ± 1.1 versus 2.8 ± 0.9); p = < 0.01. The HBB group also showed 
significantly less T2W motion and T2W blur than the non-HBB group (23.0% and 51.7% 
versus 53.5% and 83.7%, respectively; p = < 0.01). However, there was no significant 
improvement in DWI or ADC image quality, or DWI degree of distortion or artefact. There 
was a trend towards a lower number of corrupted data points from the contrast curve (2.5 ± 2.4 
versus 3.7 ± 2.6), p = 0.05. 
The third study showed a significant correlation between increased rectal distension and both 
reduced DW image quality (r = -0.628, p < 0.01), and increased DW image distortion (r=0.814, 
p < 0.01). There was a significant trend for rectal distension to increase artefact at DWI (r = 
0.154, p = 0.04) and to increase motion artefact on T2 (p < 0.01). There was no relationship 
between rectal distension and T2-sharpness or DCE image quality. 63 patients underwent 
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lesion-targeted biopsy post MRI, there was a trend to higher positive predictive values in 
patients with minor rectal distension compared to those with moderate/marked distension. 
Conclusions 
The use of 3D-T2 showed significantly increased sensitivity and confidence in calling ECE 
over conventional 2D-T2. In addition, capsular contact length threshold was significantly 
longer for LGG than HGG lesions. Rectal distension had a significant negative effect on the 
quality of both T2W and DW images whereas the administration of HBB was significantly 
associated with improved image quality of T2W images.  
Consideration should therefore be given to 3D-T2W imaging for improved detection of ECE 
as well as to bowel preparation and the routine use of HBB to optimise image quality of mpMRI 
of prostate. 
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POVZETEK 
Ozadje 
Slikanje z magnetno resonanco (MR) se je uveljavilo kot standardna diagnostična metoda pri 
odkrivanju in oceni lokalne razširjenosti raka prostate (RP), pri čemer je osnovni predpogoj 
dobra kvaliteta slik. Le-to bi lahko nadgradili z vključitvijo tridimenzionalnega T2-obteženega 
slikanja (3 dimensional T2-weighted imaging, 3D-T2WI) v standardni protokol, saj omogoča 
rekonstrukcijo slik v poljubni ravnini, s čimer bi lahko bolje prikazali stik tumorja z ovojnico 
prostate. Neodvisno od tehnike slikanja vplivajo na kvaliteto slik še različni dejavniki pri 
bolnikih kot sta črevesna peristaltika in prekomerna razširjenost danke. Smernice PI-RADS 
(Prostate Imaging-Reporting and Data System) poudarjajo pomanjkanje dokazov na obeh 
področjih in zato ne vsebujejo navodil glede priprave pacienta pred MR slikanjem.  
Namen 
Naš namen je bil primerjati 3D-T2WI z običajnim dvodimenzionalnim T2-obteženim 
slikanjem (2D-T2WI) pri opredelitvi lokalne razširjenosti RP. Želeli smo tudi raziskati vpliva 
antispazmolitika hioscin butilbromida (HBB) in razširjenosti danke na kvaliteto anatomskega 
in funkcijskega MR slikanja prostate.  
Preiskovanci in metode 
Vse študije smo opravili na 3 Tesla (3T) MR-tomografu v skladu s PI-RADS protokolom, ki 
je vključeval T2-obteženo slikanje (T2-weighted imaging, T2WI), T1-obteženo slikanje (T1-
weighted imaging, T1WI), difuzijsko obteženo slikanje (Diffusion weighted imaging, DWI) z 
maksimalno b-vrednostjo 2000s/mm2, navidezni difuzijski koeficient (Apparent diffusion 
coefficient, ADC) in  dinamično kontrastno ojačano slikanje (Dynamic contrast enhanced 
imaging, DCEI). 
V prvo študijo je bilo vključenih 75 preiskovancev po radikalni prostatektomiji, ki so pred tem 
opravili MR slikanje prostate. Najprej smo na 2D-T2W slikah lezije z vrednostmi PI-RADS ≥ 
4 na 5-stopenjski lestvici Likert (1 = ne prerašča, 5 = prerašča) subjektivno ocenili ali 
preraščajo ovojnico (extracapsular extension, ECE) ter izmerili dolžino kontakta med 
tumorjem in ovojnico. Nato smo branje ponovili z uporabo 3D-T2WI, kjer smo dodatno 
rekonstruirali potrebne ravnine, da smo določili maksimalni 3D kontakt in 3D površino.  
V drugo študijo II je bilo vključenih 87 bolnikov, ki so pred MR slikanjem prejeli 20 mg 
hioscinijevega butilbromida (HBB skupina) in 86 bolnikov v kontrolni skupini, ki HBB niso 
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prejeli. Dva radiologa sta ovrednotila kvaliteto T2W, DWI in ADC slik s 5-stopenjsko Likert-
ovo lestvico. DWI smo dodatno ocenili glede na stopnjo distorzije in artefaktov in T2W na 
prisotnost artefaktov zaradi premikanja in zmanjšane ostrine slike. Kvaliteto DCEI smo 
ovrednotili glede na število popačenih vrednosti na kontrastni krivulji. 
V tretji študiji sta MR slike 173 preiskovancev ovrednotila dva radiologa. Volumen danke je 
bil izračunan s planimetrijo in subjektivna ocena razširjenosti danke je bila podana s 5-
stopenjsko lestvico Likert (1 = brez blata/zraka, 5 = velika količina blata/zraka). Na DWI so 
bili ocenjeni kvaliteta in stopnja distorzije slike ter arefakti. Na T2W slikah smo ocenjevali 
prisotnost artefaktov zaradi premikanja in ostrino slike. Kvaliteto DCEI smo ocenjevali enako 
kot pri drugi študiji.  
Rezultati 
Pri prvi študiji smo ECE ocenjevali pri 106 lezijah. ECE je bil prisotna pri 54% vseh lezij z 
oceno  PI-RADS  4 in pri 64% bolnikov. ECE je bila histološko potrjena kot fokalna v 28% 
in kot makroskopska v 72%. Senzitivnost subjektivne ocene ECE s 3D-T2W slikami je bila 
neznačilno višja kot s 2D-T2W slikami (75.4% proti 64.9%, p = 0.06), specifičnost  je bila 
neznačilno nižja (83.7% proti 85.7%, p = 0.71). Ocena določena z lestvico Likert na 3D-T2W 
slikah je bila pri lezijah z ECE značilno višja (3.7 ± 1.4 versus 3.3 ± 1.4, p < 0.01), pri lezijah 
brez ECE pa neznačilno nižja (1.5 ± 1 proti 1.6 ± 0.9, p=0.27) kot pri 2D-T2W slikah. 3D 
kontakt je imel značilno višjo senzitivnost (73.7%) kot 2D kontakt (59.6%, p = 0.03), pri čemer 
je bila specifičnost enaka 87.8% (p = 1). 3D površina je značilno zvišala senzitivnost z 59.6% 
na 82.5% (p < 0.01, kar je bilo povezano z neznačilno znižano specifičnostjo z 87.8% na 71.4% 
(p < 0.01). Tumorji z visokim gradusom (High grade group, HGG) so imeli značilno višjo 
prevalenco ECE kot tumorji nizkega gradusa (low grade group, LGG): 88% proti 44%, p < 
0.01. 90.9% pozitivna napovedna vrednost (PNV) HGG tumorjev je bila dosežena pri dolžini 
kontakta ≥ 5 mm, pri LGG tumorjih je bila 90.4% PNV pri dolžini kontakta ≥ 12.5 mm. 
Druga študija II je pokazala značilno višjo kvaliteto T2W slik v HBB skupini kot v kontrolni 
skupini (3.6 ± 1.1 versus 2.8 ± 0.9); p = <0.01. V HBB skupini je bilo značilno manj artefaktov 
zaradi premikanja in zmanjšane ostrine T2W slik (23.0% proti 53.5% in 51.7% proti 83.7%, p 
= <0.01). Značilno izboljšane kvalitete DWI in ADC slik ali zmanjšane DWI distorzije in 
artefaktov v HBB skupini ni bilo. Ocena DCEI je pokazala neznačilen trend z zmanjšanim 
številom popačenih vrednosti na krivulji (2.5 ± 2.4 versus 3.7 ± 2.6), p = 0.05. 
Tretja študija je pokazala značilno negativno povezavo med razširjenostjo danke in kvaliteto 
DWI (r = -0.628, p < 0.01) ter značilno pozitivno povezavo z distorzijo DWI (r = 0.814, p < 
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0.01). Med razširjenostjo danke in prisotnostjo artefaktov na DWI (r = 0.15, p = 0.04) ter 
povečanjem artefaktov T2W slikah (p < 0.01) je bil značilen pozitiven trend. Med stopnjo 
razširjenosti danke in ostrino T2W slik ter kvaliteto DCEI ni bilo povezave. 63 bolnikov je po 
slikanju z MR imelo usmerjeno tarčno biopsijo prostate, kjer je bil opazen trend z višjo PPV 
pri bolnikih z nizko stopnjo razširjenosti danke v primerjavi z bolniki z zmerno/visoko stopnjo 
razširjenosti.  
Zaključki 
Uporaba 3D-T2W slikanja je v primerjavi s standardnim 2D-T2W slikanjem značilno zvišala 
senzitivnost in zaupanje radiologa pri diagnosticiranju ECE. Prag dolžine kontakta z ovojnico 
je bil značilno daljši pri LGG kot pri HGG tumjih. Povečana razširjenost danke je imela 
značilen negativni vpliv na kvaliteto T2W in DWI slikanja, medtem ko je HBB signifikantno 
izboljšal kvaliteto T2W slik.  
Glede na te rezultate svetujemo uporabo 3D-T2WI za boljšo odkrivanje ECE kot tudi pripravo 
črevesja in rutinsko uporabo HBB pred MR slikanjem prostate, da bi izboljšali kvaliteto slik.  
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 1 
INTRODUCTION / UVOD 
Prostate cancer (PCa) is the commonest malignancy in Slovenian and European men 
accounting for almost 1800 and 450.000 new cases in 2018, respectively [1]. The incidence 
has been steadily increasing over the last two decades mainly due to aging population and the 
introduction of prostate specific antigen (PSA) testing [2]. PCa is the second leading cause for 
cancer related mortality in males, although the 1 and 5-year relative survival for PCa is high at 
95% and 83%, respectively, with the mortality trend further decreasing in most European 
regions including Slovenia [1, 2]. 
 
Diagnosis of PCa has traditionally relied on elevated prostate specific antigen (PSA) levels and 
abnormal digital rectal examination (DRE) followed by systematic transrectal ultrasound 
(TRUS) guided biopsy for histological confirmation [3]. However, diagnostic value of this 
approach is suboptimal due to the low negative predictive value (NPV) of TRUS biopsy, which 
misses up to 30% of clinically significant prostate cancers (csPCa) at initial biopsy [3, 4]. The 
NPV of mpMRI is significantly higher [5] reaching almost 90% [5] and in combination with 
clinical risk assessment can potentially obviate the need for biopsy in 25-30% of men [6, 7]. In 
addition, when performed prior to biopsy it allows for precise targeting of the suspicious 
lesion/s thereby reducing the number of repeated biopsies as well as providing more accurate 
estimation of tumour grade. As a result, detection of csPCa is increased whilst at the same time 
over-diagnosis of clinically insignificant cancer is reduced [6, 7]. Therefore in many centres, 
mpMRI is now increasingly being performed prior to biopsy.  
 
Once a lesion is detected, accurate staging should be performed in order to ensure appropriate 
risk assessment and stratify patients for appropriate management where the main aim is to 
differentiate between organ-confined disease and extracapsular extension (ECE) which is 
associated with higher rate of positive surgical margins, biochemical recurrence and micro-
metastatic disease [8, 9]. MRI has been shown to have higher accuracy for prediction of ECE 
than conventional staging based on clinical nomograms such as Partin tables which incorporate 
clinical parameters including digital rectal examination (DRE), prostate-specific antigen (PSA) 
levels, Gleason score and percentage core involvement as a surrogate of lesion volume [10–
12]. It also provides additional information on the site and extent of disease, however, whilst 
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performance of mpMRI for lesion detection is high, accuracy of MRI with conventional 
sequences in detecting ECE is only moderate mainly due to its limited sensitivity [13].  
 
Given the central role of prostate MRI in evaluation and management of PCa, imaging of the 
highest quality is essential. Patient factors such as bowel peristalsis and rectal distension by 
gas/stool can affect image quality by inducing motion and susceptibility artefacts, respectively. 
The Prostate Imaging-Reporting and Data System (PI-RADS) guidelines acknowledge that 
there is currently lack of evidence in both areas and therefore no direct recommendation on 
patient preparation is given [14]. Independent of patient factors, quality of imaging could 
potentially be further improved by adding modern techniques to standard protocol such as 
three-dimensional T2-weighted imaging (3D-T2WI). 3D-T2WI would potentilly allow us to 
better demonstrate the tumour/capsular interface and thus improve the detection of ECE, which 
is known to be limited with the existing sequences. Our aim was therefore to evaluate the effect 
of anti-peristaltic agent and rectal distension on the quality of mpMRI and to assess the added 
value of 3D-T2W imaging in evaluation of extracapsular extension of PCa.   
 
Standard MpMRI protocol 
In 2015, European Society of Urogenital Radiology and American College of Radiology 
published an extended second version of the prostate imaging and reporting data system (PI-
RADS) recommendation guidelines [14] which have been recently updated [15] and are aimed 
at standardising MRI acquisition and interpretation. MpMRI includes three key sequences: 
high-resolution anatomical T2-weighted imaging (T2WI), in combination with two functional 
MR sequences, namely diffusion-weighted imaging (DWI), and dynamic contrast-enhanced 
(DCE) imaging. T2W is the essential sequence in every prostate MRI protocol enabling an 
overview of anatomy (Figure 1), detection of lesions, and local staging of PCa. The principle 
of the "dominant sequence" is formally introduced in PI-RADS where T2W is the dominant 
sequence for lesion detection in the transition zone (PZ) and DWI in the peripheral zone (TZ) 
with the DCE having only minor role in assessment of equivocal peripheral zone lesions. A 
final PI-RADS score is then derived on a 5-point scale where biopsy is typically recommended 
for lesions with a PI-RADS score ≥ 3.  
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Figure 1: Normal prostate anatomy. T2W imaging shows the peripheral zone (PZ) with high 
signal intensity and transitional zone (TZ) of lower signal intensity in the axial (A), coronal 
(B) and sagittal (C) plane. Central zone is demonstrated as a hypointense area surrounding 
ejaculatory ducts (*) on the coronal image (B). Arrow shows seminal vesicles (B, C).  
 
 
In addition to lesion detection, PI-RADS guidelines also recommend an approach for local 
staging of PCa by listing morphological criteria for assessment of extracapsular extension 
(ECE) and seminal vesicle invasion (SVI) (Table 1) [14]. T2W imaging is the key sequence 
for local T-staging of the prostate due to its high in-plane spatial resolution, whilst functional 
imaging has an added value for improving accuracy [16–18], (Figure 2).  
 
Figure 2: PI-RADS 5 lesion with extracapsular extension (ECE). T2W imaging (A) shows a 
low signal lesion (arrows) in the right midgland peripheral zone with restricted diffusion on 
DWI (B) and ADC (C). Note the length of capsular contact at 1.7 cm suggesting ECE (A).   
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Table 1: PI-RADS criteria for assessment of ECE and SVI 
Criteria for ECE Criteria for SVI 
Capsular abutment Focal or diffuse low T2 signal intensity 
Capsular irregularity or retraction  Obliteration of the angle between the base of 
the prostate and the seminal vesicle 
Neurovascular bundle asymmetry or 
thickening  
Direct tumour extension from the prostate 
base into and around the seminal vesicle 
Obliteration of the rectoprostatic angle Abnormal contrast enhancement within or 
along seminal vesicle 
Capsular signal loss or bulging  Restricted diffusion within the seminal 
vesicle 
Tumour-capsular contact > 10 mm  
Measurable extracapsular disease   
ECE = extracapsular extension, SVI = seminal vesicle invasion 
 
Limitations of MRI 
Diagnostic performance of MRI and PI-RADS scoring system in PCa detection was evaluated 
in a meta-analysis by Woo et al. from 2017 reporting sensitivity and specificity of 89% and 
73%, respectively [19]. Sub-analysis of technical considerations including the type of coil used 
e.g. endorectal coil (ERC) versus surface body coil and the strength of magnet utilised (1.5T 
versus 3T) revealed variation in performance across the studies suggesting image quality is key 
and therefore needs optimising. Image quality of the sequences comprising mpMRI depends 
on the hardware and software utilized and scanning parameters selected, but also on several 
other patient related factors including bowel peristalsis and rectal distension. The current PI-
RADS guidelines which are aimed at standardising MRI acquisition and interpretation 
highlight the lack of evidence in both these areas of patient preparation and therefore no direct 
recommendations are proposed [14, 20]. 
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Another area which requires improvement is performance of MRI for local staging of PCa. 
Whilst the pooled specificity of 91% is good, the sensitivity at 57% is only moderate according 
to the meta-analysis from 2016 by de Rooij et al [21]. Sub-analysis of studies performed on 3T 
and with a full PI-RADS recommended protocol including functional imaging (DWI and DCE) 
showed increased sensitivity, but only to 68%, suggesting inherent spatial resolution 
limitations for the existing MRI sequences, and modern imaging techniques could potentially 
offer improved assessment of ECE with additional sequences such as 3D-T2W imaging.  
Three dimensional T2-weighted imaging technique 
3D-T2W sequence allows for reconstruction in multiple planes using isotropic voxels and no 
intervening gap. The resulting reduced partial volume effect and improved spatial resolution 
has been proven to be of benefit for imaging the liver, uterus and knee [22–24]. Reconstruction 
of images in any given plane would potentially allow for better demonstration of the 
tumour/capsular interface and thereby more accurately evaluate local extension of the PCa 
similar to the local MR staging of the cervix and rectum where an oblique axial plane is 
recommended in order to avoid partial volume-related staging inaccuracy [25, 26]. Two studies 
have compared the diagnostic performance of isotropic 3D-T2W sequence with the 2D-T2W 
imaging for prostate assessment by means of subjective scoring [27, 28]. While the first 
research group did not find any significant difference between the two sequences in diagnosing 
T3a disease on 3T MRI [27], the latter reported improved sensitivity of 3D-T2W imaging using 
1.5T [28]. Furthermore, good performance of 3D imaging in local staging of PCa has been 
reported by Cornud et al [29] and Matsuoka et al [30], but neither compared this with 
conventional 2D-T2W. In addition, no study to date has evaluated the incremental benefit of 
3D-T2W for measuring tumour capsular contact length, which has proven to be a potent 
biomarker in determining ECE, albeit with reported threshold values varying significantly (6 - 
20 mm) between different (2D) studies to date [31–33], compared to the PI-RADS guideline 
suggesting a cut-off of 10 mm for assessing ECE [14]. 
Patient preparation issues and artefacts 
Bowel peristalsis causes motion-related artefacts during abdominal and pelvic imaging as its 
timescale exceeds the time required for most MR imaging sequences to collect sufficient data 
to form an image [34]. This results in ghosting and blurring artefacts [35] which decrease the 
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image quality thereby compromising radiological interpretation and potentially reducing the 
diagnostic value of MR imaging. Anti-peristaltic agents such as hyoscine butylbromide (HBB) 
and glucagon have proven helpful for abdominal [36] and gynaecological examinations [37] 
but the limited studies to date in the prostate have produced conflicting results regarding the 
effect on anatomical T2W imaging [38–41]. Any benefit also needs to be considered in the 
light of additional drawbacks to administration of HBB such as extra time and side effects due 
to its anti-cholinergic properties [42]. Furthermore, to the best of our knowledge, no study has 
assessed the effect of anti-spasmodic agents on non-anatomical, functional sequences, namely, 
DWI and DCE, which are now an integral part of mpMRI of the prostate [20]. 
 
In terms of rectal distension, mpMRI is recommended to be performed either on 3T or 
optimised contemporary 1.5T scanners to provide a superior signal-to-noise ratio [14], both 
allowing the use of a surface body coil instead of an endorectal coil (ERC), which is better 
tolerated by patients, and reduces the time and cost of the examination [43]. However, the 
absence of an ERC allows for rectal loading and distension with gas/stool which may induce 
susceptibility artefact, especially on diffusion weighted images (DWI), similar to the effect 
described with neuroimaging due to the paranasal sinuses and with liver MRI in the presence 
of intrahepatic pneumobilia [44]. Susceptibility artefacts particularly affect images acquired by 
Echo Planar Imaging (EPI) which is currently the most frequently used sequence for acquiring 
DWI in the pelvis, and these are further increased in magnitude at higher 3T field strengths 
[44–46]. Such artefacts occur in areas around air and soft tissue interfaces due to their 
differences in magnetic susceptibility [44–46], causing geometric distortion and signal loss, 
which can obscure important findings and hinder interpretation. Susceptibility artefacts can 
therefore be particularly problematic in the context of prostate MRI as they occur at the 
interface of the rectum and posterior part of the prostate gland i.e. in the peripheral zone, and 
the location of approximately of 75% of tumours [47]. To date, no study has directly evaluated 
the correlation between rectal distension and the degree of artefact at mpMRI, with only one 
study assessing the effects on DWI image quality using the intervention of a cleansing enema 
[48]. In addition, in the absence of an ERC, which may serve as a mechanical barrier to 
movement of the rectum [49], rectal distension may also cause motion-related artefacts by 
inducing rectal contractions. In a study by Padhani et al. it has been shown rectal distension 
has a significant positive correlation with rectal and (secondarily) prostate movement [50], 
however, their main focus was quantifying motion during radiotherapy planning and the effect 
on the MR image quality was not assessed.   
 7 
 
OBJECTIVES / NAMEN 
Prostate mpMRI is now the established diagnostic procedure for lesion detection and staging 
and thus imaging of the highest quality is essential. However, image quality can be 
compromised by patient factors such as bowel peristalsis and rectal distension by air/faeces. In 
addition, local staging i.e. ECE assessment is known to be limited with the existing sequences 
and has potential for further improvement. The main objective of this doctoral thesis is 
therefore to evaluate 3D-T2W imaging for the assessment of extracapsular extension of PCa 
and to explore the effect of anti-peristaltic agent HBB and rectal distension on the image quality 
of mpMRI of the prostate.  
 
The secondary aim is to review the current evidence on the key factors of patient preparation 
in order to further optimise image quality of mpMRI and to review the role of mpMRI in 
complete staging of PCa.  
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HYPOTHESES / HIPOTEZE 
 
This thesis is based on the following hypotheses:  
 
 3D-T2WI improves diagnostic performance in diagnosing extracapsular extension 
(ECE) of PCa when compared to the standard 2D-T2WI by means of both subjective 
evaluation and by measuring the capsular contact length of the tumour. 
 
 Administration of hyoscine butylbromide (HBB) improves the magnetic resonance 
image quality of the prostate and decreases motion artefact and blurring. 
 
 Increased rectal distension decreases the image quality of the prostate and increases 
artefacts and distortion of the DWI. 
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PATIENTS AND METHODS / PREISKOVANCI IN METODE 
MRI protocol 
All mpMRI prostate studies were performed at 3T MRI (MR750, GE Healthcare) using a 32-
channel body coil. The standard protocol was in concordance with PI-RADS guidelines [14] 
and included: high resolution T2 weighted 2D fast recovery fast spin echo (FSE) images, axial 
T1 weighted imaging (T1WI), axial DWI with 6 signal averages; b-values of 150, 750, 1400 
and 2000s/mm2, with automated ADC maps. Axial DCE images were acquired using a fast-
spoiled gradient echo sequence and a bolus of Gadobutrol (Gadovist, Schering AG); dose 0.1 
mmol/kg. The axial T2W, DWI and DCE sequences were spatially matched, with a 3 mm 
thickness and 0-mm gap (Table 2). 
 
Table 2: MRI protocol parameters 
Parameter T1W Axial T2 2D FSE EPI-2D DWI DCE 3D T1W 
GRE 
TR / TE (msec) 561/11 3712/102 3775/70 4088/1788 
Flip angle (°) 111 111 90 13 
ETL length 4 16 1 N/A 
Averages  1.5 6  
b value 
N/A N/A 150, 750, 
1400, 2000 
N/A 
Section 
thickness (mm) 
8 3 3 3 
Section gap 
(mm) 
4 0 0 0 
FOV (mm) 
240 × 240 220 × 220 280 × 280 240 × 240 
Resolution 
(mm) 
11 × 1 0.85 × 0.57 2.2 × 2.2 ≤2mm × ≤2mm  
Acquisition 
time (min:sec) 
03:47 04:39 02:58 05:57 (temporal 
resolution 7s) 
FSE = Fast spin echo, FOV = field-of-view, ETL = echo train length. 
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First study: Defining the incremental value of 3D T2-weighted imaging in the 
assessment of prostate cancer extracapsular extension 
Ethics 
This single-institution retrospective study was approved by the local ethics committee 
(reference HBREC.2016.08) with the need for obtaining informed consent waived (Appendix 
4). 
Patients 
In total 75 consecutive patients who underwent radical prostatectomy (RRP) between 
September 2014 and January 2017 were included. Inclusion criteria included: (1) preoperative 
3T mpMRI and (2) subsequent RRP for clinically localised (stage T1 - T2) prostate cancer. 
Exclusion criteria included presence of (1) total hip replacement and (2) any previous treatment 
for prostate cancer. 
MRI Protocol 
In addition to the standard protocol, sagittal 3D-T2W FSE with variable flip angle (section 
thickness/gap: 1/0 mm) sequence was performed (Table 3). 
Table 3: 3D T2 Sequence protocol 
Parameter Sagittal 3D T2 FSE 
TR  / TE (msec) 3000/117 
Flip angle (°) N/A 
ETL length 90 
Averages 2 
Section thickness (mm) 1 
Section gap (mm) 0 
FOV (mm) 220 
Resolution (mm) 1.0 x 0.8 
Acquisition time (min:sec) 3:13 
FSE = Fast spin echo, FOV = field-of-view, ETL = echo train length. 
Image analysis 
Images were reviewed by a uro-radiologist, blind to the clinical details, with 8 years' experience 
in reading prostate mpMRI. 
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First read:  
The PI-RADS version 2 system was used to score all suspicious lesions detected on MRI [14]. 
Lesions with a PI-RADS score of ≥3 were then subjectively assessed for the presence of ECE 
on T2W 2D images using a 5-point Likert scale (where 1 = no, 2 = ECE unlikely, 3 = possible 
ECE, 4 = probable ECE, 5=definite ECE). This was based on the PI-RADS criteria [14], (Table 
1). For the purposes of statistical analysis, Likert scores ≥3 were considered as indicative of 
ECE. In addition, the length of contact between the lesion and the prostatic capsule was 
measured in the axial, sagittal and coronal planes of the 2D-T2W images, with the "maximum 
2D contact" representing the longest of these. 
Second read:  
There was a minimum 4-week gap following the 1st reads. The presence of ECE was evaluated 
on 3D-T2W images and its reformats in any given plane in order to better demonstrate the 
tumour/capsular interface. The same Likert scale as above was used for subjective assessment. 
As 3D allows reformatting in any 360-degree plane, a maximum length of contact between the 
lesion and the prostatic capsule was measured (3D contact). An approximation of the surface 
contact (3D-surface) was also derived using the formula for area of an ellipse (π x a/2 x b/2) 
where a stands for maximal 3D contact and b for contact perpendicular to it. Both 3D-contact 
and 3D-surface are novel quantitative parameters to predict ECE and to our knowledge have 
not been reported before (Figure 2). 
 
 
 
 
Distance a: 3D-contact 
 
Distance b: used for 3D-surface calculation 
 
Dashed line (c): axial plane where 2D-contact is 
measured 
 
Figure 2: 3D-contact is defined as maximum length of tumour in contact with prostatic 
capsule. 
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Pathological analysis 
Whole-mount radical prostatectomy specimens were used as the reference standard for ECE. 
For each patient, the prostate specimen from prostatectomy was fixed in formalin followed by 
standard step-sectioning. Lesion was outlined on hematoxylin and eosin stained sections from 
each slice by a subspecialised genitourinary pathologist. ECE was considered to represent any 
presence of the cancer cells in the periprostatic fat which was further subclassified as “focal” 
when it extended < 0.5 mm beyond the prostatic capsule in radial depth and “established” when 
≥ 0.5mm [51].  
 
Second study: Effect of hyoscine butylbromide on prostate multiparametric MRI 
anatomical and functional image quality 
Ethics 
This single-institution, retrospective study was approved as part of a prostate MRI service 
evaluation, with the need for informed consent for data analysis waived by the local ethics 
committee (reference CUH/5126; Appendix 5). 
Patients 
87 patients (HBB group) were administered 20 mg of intravenous hyoscine butylbromide 
(Buscopan, Boehringer, Ingelheim, Germany) on the MRI table, immediately prior to scanning. 
There was a matched number of patients in the control group who did not receive HBB (non 
HBB group). Inclusion criteria included patients undergoing 3T mpMRI of the prostate for any 
indication between March 2015 and February 2016. Exclusion criteria included: (1) presence 
of pelvic metalwork and (2) any previous treatment for prostate cancer. 
MRI protocol 
Standard mpMRI protocol was performed in both groups (Table 1). 
Image analysis 
Images were independently reviewed by two radiologists, blind to the clinical details, with 7-
years and 2-years’ experience in reporting prostate mpMRI . 
 
The image quality of T2WI, DWI (b = 2000 s/mm2) and ADC maps was evaluated using a 5-
point Likert scale (Table 4).  
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Table 4: Likert scale for overall image quality 
Score Desciption 
1 poor  
2 suboptimal 
3 adequate 
4 above average  
5 excellent 
 
 
T2WI was qualitatively assessed for the presence of blurring (based on sharpness of the 
prostatic capsule, neurovascular bundle, and seminal vesicles compared to the periprostatic soft 
tissues) and motion artefact (movement or ghosting). DWI was further assessed for distortion 
and artefact using 4-pointy Likert scale (Table 5) [52].  
 
Table 5: Likert scale for DWI distortion and artefact  
Score DWI distortion DWI artefact 
1 none none 
2 < 5 mm mismatch to T2W mild, not or mildly impacting diagnosis 
3 > 5 mm mismatch to T2W or mild 
warping 
artefact moderately impacting diagnosis 
4 significant warping marked artefact, non-diagnostic 
 
 
The quality of DCE images was evaluated by the number of corrupt data points from contrast 
curve. A region-of-interest of at least 0.2 cm3 was placed in normal appearing peripheral zone, 
and the number of corrupted data points from the curve was recorded (defined as a >10% signal 
intensity change between any of the time points during the wash-out phase) [53]. 
 
Third study: Evaluating the effect of rectal distension on prostate multiparametric 
MRI image quality 
Ethics 
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This single-institution, retrospective study was approved as part of a prostate MRI service 
evaluation, with the need for informed consent for data analysis waived by the local ethics 
committee (registration CUH/5126; Appendix 5). 
Patients 
The study included 170 patients undergoing prostate 3T-MRI for any indication. Exclusion 
criteria included presence of pelvic metalwork and any previous treatment for prostate cancer. 
MRI protocol 
Standard mpMRI protocol was performed in all patients (Table 1). 
Image analysis 
Images were independently reviewed by two radiologists, blind to the clinical details. 
Planimetry rectal volumes were derived using maximal axial and sagittal dimensions (anal 
canal to peritoneal reflection) and a subjective assessment of rectal distension was made using 
a 5-point Likert scale (where 1=no stool/gas, 5=large amount of stool/gas). Image quality of 
DWI was scored on the high b-value images (b = 2000 series) using a 5-point Likert scale 
(Table 4). DWI was also assessed for artefact and distortion using 4-point scales (Table 4) [52]. 
T2WI was qualitatively assessed for image sharpness and motion artefacts, based on the same 
criteria as in the second study.  
Statistical analysis  
The Shapiro-Wilks test was used to assess distributional normality. Non-parametric 
distributions were reported using median and inter-quartiles (IQ). 
Receiver operating characteristic (ROC) analysis was used to assess the diagnostic utility 
associated with the Likert scores and measured length of capsular contact from 2D T2WI and 
3D T2WI for the detection of ECE. In particular, the ROC analysis was performed to identify 
the optimal threshold for the length and surface of different capsular contact types. Specifically, 
the Youden index was used to define a single optimal threshold maximizing the average of 
sensitivity and specificity. DeLong test was applied to compare two AUC curves. 
Chi-square test (χ2) was performed to compare MRI indications against HBB grouping. The 
Wilcoxon signed ranked test was performed to assess differences between the ordinal variables. 
Spearman’s correlation was performed to assess the relationship between ordinal variables. 
Fisher’s exact test was performed to compare proportions. Weighted Cohen’s kappa was 
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performed to assess inter-rater agreement, where 0-0.20 = slight, 0.21-0.40 = fair, 0.41-0.60 = 
moderate, 0.61-0.80 = substantial, and 0.81-1 = almost perfect agreement. 
A p-value of <0.05 was defined as statistically significant. 
All statistical analyses were performed using SPSS 24.0 and R package software (version 3.1.1, 
The R Foundation for Statistical Computing, Vienna, Austria). 
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RESULTS / REZULTATI 
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DEFINING THE INCREMENTAL VALUE OF 3D T2-WEIGHTED IMAGING IN 
THE ASSESSMENT OF PROSTATE CANCER EXTRACAPSULAR EXTENSION 
ABSTRACT 
Aim  
To assess the added value of 3D-T2 weighted imaging (T2WI) over conventional 2D-T2WI in 
diagnosing extracapsular extension (ECE) of prostate cancer (PCa). 
 
Materials and methods 
75 patients undergoing 3T MRI before radical prostatectomy were included. PI-RADS ≥4 
lesions were assessed for ECE on 2D-T2W images using a 5-point Likert scale (1=no ECE, 
5=definite ECE) and the length of tumour prostatic capsular contact. A second read was 
performed after a minimum 4 weeks’ time gap using 3D-T2W images and reformats where 
ECE and the maximal 3D capsular contact length and surface were evaluated.  
 
Results 
106 lesions were identified at MRI. ECE was confirmed by histology in 54% (57/106) of 
lesions and 64% (48/75) of patients. Sensitivity and specificity for 3D-T2 reads was 75.4% 
versus 64.9% (p=0.058), respectively and 83.7% versus 85.7% (p=0.705) for 2D-T2 reads, 
respectively. 3D-T2W reads showed significantly higher mean subjective Likert scores of 3.7 
± 1.4 versus 3.3 ± 1.4 (p=0.001) in ECE positive lesions and lower mean Likert score of 1.5 ± 
1 versus 1.6 ± 0.9 (p=0.27) in ECE negative lesions compared to 2D-T2W reads. 3D contact 
significantly increased sensitivity from 59.6% to 73.7% (p=0.03), whilst maintaining the same 
specificity of 87.8% (p=1). High grade group tumours (≥ Gleason 4+3) showed significantly 
higher ECE prevalence than low grade tumours (88% versus 44%, p<0.001) and a PPV for 
ECE of 90.9% with ≥5 mm of contact versus PPV of 90.4% at ≥12.5 mm for lower grade 
tumours. 
 
Conclusions 
3D-T2WI significantly increases sensitivity and confidence in calling ECE. The capsular 
contact length threshold differed between low and high grade cancers.   
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OPREDELITEV DODANE VREDNOSTI 3D T2-OBTEŽENEGA SLIKANJA PRI 
OCENJEVANJU EKTRAKAPSULARNE RAZŠIRJENOSTI RAKA PROSTATE  
IZVLEČEK 
Namen  
Opredeliti dodano vrednost 3D T2-obteženega slikanja (three dimensional T2-weighted, 3D-
T2W) v primerjavi z običajnim 2D T2-obteženim slikanjem (2 dimensional T2-weighted, 2D-
T2W)  pri diagnostiki lokalne razširjenosti raka prostate (RP). 
 
Materiali in metode 
Vključili smo 75 bolnikov, ki so opravili slikanje prostate s 3 Tesla (3T) MR-aparatom pred 
radikalno prostatektomijo. Lezije z oceno po PI-RADS (Prostate Imaging-Reporting and Data 
System) ≥ 4 so bile subjektivno ovrednotene s 5-stopenjsko Likertovo lestvico glede na 
verjetnost preraščanja ovojnice (1 = ne prerašča, 5 = prerašča); izmerili smo tudi dolžino 
kontakta med tumorjem in ovojnico. Najprej smo uporabili standardne 2D-T2W slike, po 
minimalno 4 tednih premora smo ocenjevanje ponovili še s 3D-T2W slikami. Pri tem smo 
rekonstruirali dodatne poljubne ravnine in tako izmerili najdaljši 3D kontakt ter izračunali 3D 
površino med lezijo in ovojnico. 
 
Rezultati 
Na MR slikah smo odkrili 106 lezij z oceno PI-RADS ≥ 4. Razširjenost raka preko ovojnice je 
bila histološko potrjena pri 54% (57/106) lezij in 64% (48/75) bolnikov. Senzitivnost 
subjektivne ocene s 3D-T2WI v primerjavi s standardnim 2D-T2WI je bila višja (75.4% in 
64.9%), vendar ni dosegla statistične značilnosti (p = 0.058), specifičnost se pri tem ni značilno 
znižala (83.7% proti 85.7%, p = 0.705). Uporaba 3D-T2W slik je imela pri lezijah, ki so 
preraščale ovojnico, značilno višjo povprečno oceno Likert kot standardne 2D slike (3.7 ± 1.4 
proti 3.3 ± 1.4, p = 0.001) in neznačilno nižjo povprečno oceno Likert pri lezijah omejenih na 
prostato (1.5 ± 1 in 1.6 ± 0.9, p = 0.27). 3D kontakt je statistično pomembno zvišal senzitivnost 
z 59.6% na 73.7% (p = 0.03), pri čemer je specifičnost ostala enaka pri 87.8% (p = 1). Tumorji 
visokega gradusa (High grade group, HGG) (≥ Gleason 4 + 3) so imeli značilno višjo 
prevalenco preraščanja ovojnice kot tumorji z nizkim gradusom (Low grade group, LGG) (88% 
proti 44%, p < 0.001) in so dosegli pozitivno napovedno vrednost (PNV) = 90.9% pri dolžini 
kontakta ≥ 5 mm, medtem ko so LGG dosegli PNV = 90.4% pri dolžini kontakta ≥ 12.5 mm. 
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Zaključki 
Uporaba 3D-T2W slikanja značilno zviša senzitivnost in zaupanje radiologa pri diagnostiki 
lokalne razširjenosti RP. Prag dolžine kontakta z ovojnico se je razlikoval med LGG in HGG 
tumorji. 
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EFFECT OF HYOSCINE BUTYLBROMIDE ON PROSTATE MULTIPARAMETRIC 
MRI ANATOMICAL AND FUNCTIONAL IMAGE QUALITY 
ABSTRACT 
Aim 
To evaluate the effect of the spasmolytic agent hyoscine butylbromide (HBB) on the quality of 
anatomical and functional imaging of the prostate. 
 
Materials and Methods 
173 patients were included in this retrospective study. 87 patients received intravenous HBB 
prior to scanning (HBB group) and 86 patients did not (non-HBB group). Multiparametric (mp) 
3T-MRI was performed using a 32-channel body coil. Two radiologists independently 
evaluated image quality of T2WI, diffusion-weighted imaging (DWI) and ADC maps, using a 
5-point Likert scale. DWI was further assessed for distortion and artefact (4-point Likert scale), 
and T2WI for the presence of motion artefact or blurring. DCE image quality was assessed by 
recording the number of corrupt contrast curve data points.  
 
Results 
T2W image quality in the HBB group was significantly higher than in the non-HBB group 
(3.63 ± 1.11 versus 2.84 ± 0.899); p < 0.001. The HBB group also showed significantly less 
T2W motion and T2W blur than the non-HBB group (23.0% and 51.7% versus 53.5% and 
83.7%, respectively; p < 0.001). However, there was no significant improvement in DWI or 
ADC image quality, or DWI degree of distortion or artefact. There was a trend towards a lower 
number of corrupted data points from the contrast curve (2.47 ± 2.44 versus 3.68 ± 2.64), but 
this did not reach significance (p = 0.052). 
 
Conclusion 
Administration of HBB significantly improves the image quality of T2-weighted images. These 
results provide evidence for the use of HBB in routine patient preparation prior to prostate 
mpMRI.  
 
  
 35 
 
VPLIV HIOSCINIJEVEGA BUTILBROMIDA NA KVALITETO ANATOMSKIH IN 
FUNKCIJSKIH SEKVENC MULTIPRAMETRIČNE MR PROSTATE  
IZVLEČEK 
Namen 
Ovrednotiti vpliv spazmolitika hioscinijevega butilbromida (HBB) na kvaliteto slik 
anatomskih in funkcionalnih sekvenc multiparametrične magnetno resonančne (mpMR) 
preiskave prostate. 
 
Materiali in metode 
V študijo smo vključili 173 bolnikov. 87 bolnikom smo pred preiskavo intravenozno aplicirali 
HBB (HBB skupina), 86 bolnikov HBB ni prejelo (kontrolna skupina). Za slikanje smo 
uporabili mpMR in 32-kanalno tuljavo. Dva radiologa sta neodvisno ocenila kvaliteto T2-
obteženih slik (T2-weighted images, T2WI), difuzijsko obteženih slik (Diffusion weighted 
imaging, DWI) in map navideznega difuzijskega koeficienta (Apparent diffusion coefficient 
map, ADC map) z uporabo 5-stopenjske lestvice Likert. Na DWI slikah smo dodatno ocenili 
distorzijo slike in artefakte (4-stopenjska lestvica Likert), na T2W slikah pa prisotnost 
artefaktov zaradi premikanja in zmanjšanja ostrine slike. Kvaliteto dinamičnega kontrastno 
ojačanega (Dynamic contrast enhanced, DCE) slikanja smo ovrednotili glede na število 
popačenih vrednostih na kontrastni krivulji. 
 
Rezultati 
Kvaliteta T2W slik je bila značilno višja v HBB kot v kontrolni skupini (3.63 ± 1.11 proti 2.84 
± 0.899); p < 0.001. HBB skupina je imela značilno manj artefaktov premikanja in zmanjšanja 
ostrine kot kontrolna skupina (23.0% in 51.7% proti 53.5% in 83.7%); p = <0.001. Značilnih 
razlik v kvaliteti DWI in DCE slik ni bilo. Prav tako ni bilo značilnih razlik v artefaktih ali 
distorziji DWI. HBB skupina je imela manj popačenih vrednostih na DCE krivulji kot 
kontrolna skupina, vendar to ni bilo statistično značilno (2.47 ± 2.44 versus 3.68 ± 2.64); p = 
0.052. 
 
Zaključki 
Administracija HBB značilno izboljša kvaliteto T2W slik.  Ti rezultati podpirajo uporabo HBB 
kot del rutinske priprave bolnika pred MR slikanjem prostate.  
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EVALUATING THE EFFECT OF RECTAL DISTENSION ON PROSTATE 
MULTIPARAMETRIC MRI IMAGE QUALITY 
ABSTRACT 
Aim 
To evaluate the effect of rectal distension on the quality of anatomical and functional prostate 
multiparametric (mp) MRI. 
 
Materials and Methods  
Multiparametric (mp) 3T-MRI images of 173 patients were independently evaluated by two 
radiologists in this retrospective study. Planimetry rectal volumes were derived and a 
subjective assessment of rectal distension was made using a 5-point Likert scale (1 = no 
stool/gas, 5 = large amount of stool/gas). Image quality of diffusion-weighted imaging (DWI) 
was evaluated using a 5-point Likert scale. DWI was further scored for distortion and artefact. 
T2W images were evaluated for image sharpness and the presence of motion artefact. The 
stability of the dynamic contrast-enhancement acquisition was assessed by recording the 
number of corrupt data points during the wash-out phase. 
  
Results 
There was a strong correlation between subjective scoring of rectal loading and objectively 
measured rectal volume (r = 0.82), p < 0.001. A significant correlation was shown between 
increased rectal distension and both reduced DW image quality (r = -0.628, p < 0.001), and 
increased DW image distortion (r = 0.814, p < 0.001). There was also a significant trend for 
rectal distension to increase artefact at DWI (r = 0.154, p = 0.042). Increased rectal distension 
led to increased motion artefact on T2 (p = 0.0096), but did not have a significant effect on T2-
sharpness (p = 0.0638). There was no relationship between rectal distension and DCE image 
quality (p = 0.693). 63 patients underwent lesion-targeted biopsy post MRI, there was a trend 
to higher positive predictive values in patients with minor rectal distension (34/38, 89.5%) 
compared to those with moderate/marked distension (18/25, 72%), p = 0.09. 
 
Conclusion 
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Rectal distension has a significant negative effect on the quality of both T2W and DW images. 
Consideration should therefore be given to bowel preparation prior to prostate mpMRI to 
optimise image quality. 
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OCENA VPLIVA RAZŠIRJENOSTI DANKE NA KVALITETO 
MULTIPARAMETRIČNIH MR SLIK PROSTATE 
IZVLEČEK 
Namen 
Ovrednotiti vpliv razširjenosti danke na kvaliteto anatomskega in funkcionalnega slikanja 
prostate z multiparametrično magnetno resonanco (mpMR).  
 
Materiali in metode 
MpMR slike 173 bolnikov sta neodvisno ocenila dva radiologa. Prostornino danke smo 
izračunali s planimetrijo, subjektivna ocena razširjenosti danke pa je bila ovrednotena na 5-
stopenjski lestvici Likert (1 = brez blata/zraka, 5 = velika količina blata/zraka). Kvaliteta 
difuzijsko obteženih slik (Diffusion weighted imaging, DWI) smo ovrednotili s 5-stopenjsko 
lestvico Likert ter nadalje ocenili glede na prisotnost distorzije in artefaktov. Na T2-obteženih 
(T2-weighted, T2W) slikah smo ocenili ostrino in prisotnost artefaktov zaradi premikanja. 
Stabilnost dinamično kontrastno poudarjenega (Dynamic contrast enhanced, DCE) slikanja  
smo ovrednotili glede na število popačenih točk na kontrastni krivulji med fazo izplavljanja. 
 
Rezultati 
Subjektivna ocena razširjenosti danke in objektivno izmerjena prostornina danke sta bili 
značilno močno povezana (r = 0.82), p < 0.001. Med bolj razširjeno danko in kvaliteto DWI je 
bila značilna negativna povezanost (r = -0.628, p < 0.001) ter značilna pozitivna povezanost z 
distorzijo DWI (r = 0.814, p < 0.001). Razširjenost danke je značilno zvišala artefakte na DWI 
(r = 0.154, p = 0.042). Povečana razširjenost danke je tudi zvišala pojavnost artefaktov zaradi 
premikanja na T2WI (p = 0.0096), vpliv na ostrino T2W slik pa ni bil značilen (p = 0.0638). 
Povezave med razširjenostjo danke ter kvaliteto DCEI ni bilo (p = 0.693). Pri 63 bolnikih je 
bila po slikanju z MR opravljena usmerjena biopsija prostate, kjer je bil trend k višji pozitivni 
napovedni vrednosti pri bolnikih z nižjo stopnjo razširjenosti danke (34/38, 89.5%) v 
primerjavi z bolniki z zmerno/izrazito razširjenostjo danke (18/25, 72%), p = 0.09. 
 
Zaključki 
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Razširjenost danke ima značilno negativen vpliv na kvaliteto T2W in DWI slik prostate, zato 
je smiselno nameniti pozornost pripravi črevesja pred mpMR slikanjem, da bi izboljšali 
kvaliteto slik.  
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DISCUSSION / RAZPRAVA 
 
This doctoral thesis explores the incremental value of 3D-T2W imaging in diagnosing ECE 
and the effect of antispasmodic agent HBB and rectal distension on the image quality of 
prostate mpMRI. In this section the main study results and their original contribution to 
knowledge will be discussed. More detailed discussions of specific study results and limitations 
are part of the research articles (chapters 1 - 3), whilst general overview of local staging of PCa 
with mpMRI and factors of patient preparation prior to prostate MRI are provided in the review 
articles within the following chapters 3 and 4, respectively.  
 
3D T2-weighted imaging in local staging of prostate cancer 
 
The results demonstrate the added value of 3D-T2 imaging over conventional 2D-T2 for the 
detection of ECE. Our suggested quantitative parameters of 3D-contact and 3D-surface both 
outperformed previously reported tumour contact length measured in axial plane on 2D-T2. 
3D-contact significantly improved sensitivity from 59.6% to 73.7% whilst maintaining the 
same specificity at 87.8% thereby confirming our hypothesis that 3D-T2 imaging and its 
reformats would allow us to measure the true maximal length of capsular contact, as this is not 
necessarily longest in the axial plane. The sensitivity for 3D-measured surface area contact was 
even higher at 82.5% (2D = 59.6%), however, this was associated with decrease in specificity 
from 87.8% (2D) to 71.4%. In addition, 3D reads also improved sensitivity (from 64.9% to 
75.4%) while maintaining high specificity by means of subjective scoring, but this did not 
reach significance (p = 0.0058). However, 3D reads significantly increased the mean Likert 
score in cases positive for ECE and showed a trend towards lower mean score in negative cases, 
reflecting increased reader confidence, which may also be important from a reporting 
standpoint.  
Finally, we also show that the capsular contact length threshold differs between low grade 
group (LGG) and high grade group (HGG) cancers. Prevalence of ECE was markedly higher 
among HGG than LGG tumours (88% vs 44%, respectively; p = 0.001). Although HGG lesions 
had a longer mean capsular contact than LGG (15.3 mm vs 9.0 mm), the finding appears to be 
independent of tumour size, with a marked difference also observed when corrected for a 
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contact length of ≤10 mm (41.6% biopsy confirmed HGG index lesions showing established 
ECE vs. 3% LGG; p = 0.01). Consequently, in HGG cancers a PPV of 90.9% was achieved at 
≥5 mm, whereas a PPV of 90.4% was only reached at a cut-off at ≥12.5 mm in LGG tumours. 
This difference could be one of the reasons for variability in the previously reported thresholds 
- an essential concept not previously described.  
There are a few limitations to our study, including its single-centre and retrospective design.   
Our cohort was limited by its relatively small numbers; particularly for the sub-analysis of 
HGG versus LGG at a capsular contact of ≤10 mm. Additionally, the reader may have been 
biased by knowledge of the existing literature on capsular contact [14, 31, 33] which may 
explain the limited additional benefit of measuring capsular contact over subjective scoring 
alone.         
                                           
Effect of patient factors on image quality of prostate mpMRI 
 
The second and third study investigated the added value of spasmolytic agent (hyoscine 
butylbromide, HBB) and the effect of rectal loading on image quality of prostate mpMRI, 
respectively.  
 
The results of the second study show that the quality of T2W images in all three subcategories 
(overalll image quality, motion artefacts and blurring) was significantly better for patients 
receiving HBB. In contrast, the effect of HBB administration on the image quality of functional 
sequences (DWI and DCE) did not reach statistical significance. Our results are concordant 
with two previous studies which have reported a significant improvement in image quality of 
T2WI after HBB application [40, 41]. Recently, Ullrich et al. reported markedly improved 
visualisation of anatomical details and decreased motion artefacts in 70% of patients, thereby 
reducing non-diagnostic T2W imaging to <1% [54]. Of the two earlier negative studies, it 
should be noted that Roethke et al reported reduced artefact in all the assessed categories but 
this did not reach significance [39] and the second study used an endorectal coil (ECR), which 
may have served as a mechanical barrier to movement of the rectum and prostate thus 
minimising the added value of HBB [38]. Interestingly, as opposed to T2W imaging, we do 
not show an effect on DWI, which may reflect differences in fast spin echo versus echo planar 
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imaging acquisition and additionally its shorter acquisition, nor for DCE, which may relate to 
the half-life of the agent used and its diminished effects at time of sequence acquisition. 
The strength of this study is its sample size, which is the largest to date and that we separately 
evaluated the effect of HBB on DWI and DCE.  
 
The results of the third study show that increasing rectal distension has a significant negative 
effect on the quality of both T2W and DW images. DWI was the most affected sequence, with 
increasing rectal loading correlating to increased artefact and distortion.. For T2W imaging, 
increased rectal loading induced increased T2W motion but effect on sharpness did no reach 
statistical significance. In contrast, DCE was the only unaffected sequence. 
The echo planar readouts used within diffusion weighted imaging are very sensitive to the 
uniformity of the magnetic field which becomes distorted in areas around air-tissue interfaces 
such as prostate and gas in the adjacent rectum. T2-weighted fast spin echo images are less 
degraded because a refocusing radiofrequency pulse is used between each line of k-space which 
gets sampled. Conversely, due to the reasons explained above, there is positive correlation 
between rectal distension and T2W motion artefact [45]. 
The only two other studies looking at the question of rectal distension and image quality follow 
an intervention (use of a cleansing enema) [48, 55]. Recently, van Griethuysen et al. evaluated 
335 patients using 1.5T MRI, including patients who self-administered a micro-enema shortly 
before acquisition, and reported a significantly reduced incidence and severity of gas-induced 
artefacts [55]. In contrast, a previous smaller study at 3T showed no improvement in DWI or 
T2W image quality with the use of a pre-MRI enema, however, only a minority of patients in 
the control, non-enema group (16%) had a moderate or severely distended rectum (potentially 
minimising any potential benefit over-and-above these controls) and the use of the enema itself 
may have introduced rectal air [48].  
In terms of impact on clinical outcome, although not significant due to smaller numbers, the 
positive predictive vaule of MRI compared to targeted biopsy for the mild rectal loading group 
was higher than the group with moderate/marked rectal distension (89.5% versus 72%, 
respectively). There was a tendency to biopsy a higher percentage of patients with increasing 
rectal distension, which may reflect a reduced reader confidence in MRI quality [56]. 
The strength of this study is the relatively large sample size, separate evaluation of all the 
sequences comprising mpMRI as well as the strong inter-observer agreement.  
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Both studies have some limitations, including their single-centre and retrospective nature, 
however, a more recent prospective work has confirmed the findings from our second study 
[54]. In addition, rectal volumes were estimated using planimetry measurements and not 
calculated by more accurate measures incorporating 3D-reconstruction volumetry, however, 
previous work did not show any sigificant difference between the two [57].   
 
Original contribution to knowledge and clinical applications 
 
In the first study we propose two novel quantitative parameters for evaluation of ECE (3D-
contact and 3D-surface) which to our knowledge have not been reported before. We show 
increased sensitivity and confidence in calling ECE with 3D-T2WI which may be clinically 
important when high sensitivity reads are needed. The finding that the capsular contact length 
threshold differs between low and high grade cancers could be one of the reasons for variability 
in the previously reported thresholds - a key concept not previously described. This latter point 
is potentially of key clinical importance in the context of pre-biopsy MRI, when pathological 
information is yet to be obtained, thus it may be appropriate to re-evaluate for the likelihood 
of ECE when biopsy results become available. 
 
The second study shows the administration of HBB prior to MRI of prostate is significantly 
associated with improved image quality of T2W imaging which is a core sequence for local 
staging and evaluation of lesions in the transitional zone [15]. On the other hand, there was no 
significant effect of HBB on the image quality of DWI nor DCE. To our knowledge, this is the 
first time that comparative results have been reported on each of the sequences comprising 
mpMRI. As regards rectal distension, the third study showed a significant negative effect on 
the image quality of DWI and T2 motion, the former being an essential sequence for lesion 
detection in the peripheral zone [15].  
In summary, PIRADS guidelines highlight the lack of evidence for patient preparation prior to 
MRI [14], and these two studies are therefore of real value in helping to address this deficit in 
the literature. Our findings suggest bowel preparation and routine use of HBB prior to 
examination performed for either lesion detection or local staging is recommended in order to 
optimise image quality of prostate mpMRI. 
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MULTIPARAMETRIC MRI – LOCAL STAGING OF PROSTATE CANCER AND 
BEYOND 
 
ABSTRACT 
 
Background 
Accurate local staging is critical for treatment planning and prognosis in patients with prostate 
cancer (PCa). The primary aim is to differentiate between organ-confined and locally advanced 
disease with the latter carrying a worse clinical prognosis. Multiparametric (mp) MRI is the 
imaging modality of choice for the local staging of PCa and has an incremental value in 
assessing pelvic nodal disease and bone involvement. It has shown superior performance 
compared to traditional staging based on clinical nomograms, and provides additional 
information on the site and extent of disease. MRI has a high specificity for diagnosing 
extracapsular extension (ECE), seminal vesicle invasion (SVI) and lymph node (LN) 
metastases, however, sensitivity remains poor. As a result, extended pelvic LN dissection 
remains the gold standard for assessing pelvic nodal involvement, and there has been recent 
progress in developing advanced imaging techniques for more distal staging.  
 
Conclusions 
T2W-weighted imaging is the cornerstone for local staging of PCa. Imaging at 3T and 
incorporating both diffusion weighted and dynamic contrast enhanced imaging can further 
increase accuracy. “Next generation” imaging including whole body MRI and PET-MRI 
imaging using prostate specific membrane antigen (68Ga-PSMA), has shown promising for 
assessment of LN and bone involvement as compared to the traditional work-up using bone 
scintigraphy and body CT.   
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MULTIPARAMETRIČNA MR – DOLOČANJE STADIJA RAKA PROSTATE  
 
IZVLEČEK 
Ozadje 
Natančna ocena lokalne razširjenosti bolezni je bistvena za načrtovanje zdravljenja in napoved 
poteka bolezni pri bolnikih z rakom prostate. Predvsem želimo ugotoviti, ali je bolezen 
omejena na organ ali pa je lokalno napredovala in je zato napoved poteka bolezni slabša. 
Slikanje z multiparametrično magnetno resonanco (MR) je metoda izbora za oceno lokalne 
razširjenosti raka prostate in ima dodano vrednost pri opredelitvi medeničnih bezgavk in 
skeleta medenice. V primerjavi s tradicionalnimi metodami, ki temeljijo na kliničnih 
nomogramih, dodatno poda informacijo o lokaciji in stopnji razširjenosti bolezni. MR ima 
visoko specifičnost pri diagnozi ekstrakapsularne razširjenosti, invaziji seminalnih vezikul in 
zasevkih v bezgavkah, vendar senzitivnost ostaja slaba. Zato je še vedno zlati standard pri 
določitvi stadija bezgavk razširjena limfadenektomija pelvičnih bezgavk, v zadnjem času pa je 
bil tudi dosežen napredek v razvoju naprednih slikovnih tehnik, ki določijo celotni stadij. 
 
Zaključki 
T2-obteženo slikanje je osnovna sekvenca pri določanju lokalne razširjenosti raka prostate. 
Natančnost lahko zviša slikanje z magnentnoresonančnim aparatom 3T ter vključitev 
difuzijsko obteženega in dinamično kontrasno ojačanega slikanja. 
Tako imenovana naslednja generacija slikanja, ki vključuje MR celotnega telesa in PET-MR z 
uporabo specifičnega membranskega antigena prostate (68Ga-PSMA), je omogočila 
vzpodbudne rezultate pri odkrivanju zasevkov v bezgavke in kosti v primerjavi z običajnimi 
protokoli. 
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Introduction 
 
Accurate staging of prostate cancer is essential to inform prognosis and to stratify patients for 
appropriate management. MRI affords excellent soft tissue differentiation making it the most 
accurate modality for preoperative local T-staging of prostate cancer.1 According to European 
Association of Urology (EAU) guidelines, local staging investigations are only indicated for 
intermediate and high-risk patient groups1. The high accuracy of multiparametric MRI 
(mpMRI) for detection of index lesions can aid T-staging, and can also identify tumours that 
may be missed by systematic biopsies, enabling early re-biopsy and accurate risk stratification.2 
For the purposes of prognosis and management the primary aim is to differentiate 
organ-confined disease from locally advanced disease. Extracapsular disease and seminal 
vesicle invasion carry a worse prognosis due to a greater risk of positive surgical margins 
leading to biochemical recurrence3,4 and an increased risk of lymph node (LN) metastases, 
respectively.5 Nodal disease on its own is associated with a higher risk of progression to 
metastatic disease and thus a higher rate of cancer specific mortality.6-8 
Traditionally, staging of prostate cancer has been performed using nomograms such as 
Partin tables which are based on digital rectal examination (DRE), prostate-specific antigen 
(PSA) levels, Gleason score and percentage core involvement as a surrogate of lesion volume.9-
11 This approach often underestimates the true stage of the disease and has been shown to be 
inferior to MRI12, with the combination of MRI findings and nomograms showing significant 
added value for predicting adverse pathology in prostate cancer.13 In addition to improving 
accuracy, MRI also provides information on the site and extent of disease, which helps surgical 
planning, informing decision making on taking wider surgical margins to decrease the rate of 
positive margins, or performing nerve-sparing surgery to decrease morbidity. In case of a gross 
extracapsular extension or seminal vesicle invasion on MRI, external beam radiotherapy is a 
recommended approach over brachytherapy or surgery, to avoid under dosing or positive 
surgical margins, respectively.14 As MR imaging currently does not offer sufficient diagnostic 
performance, extended pelvic lymph node dissection (ePLND) remains the gold standard for 
N-staging.1 However, ePLND has its own disadvantages including higher morbidity, with 
worse intraoperative and perioperative outcomes, and may result in under-sampling, thus its 
direct therapeutic effect is equivocal.15 
This review aims to summarize the role of MRI in staging prostate cancer and focuses 
mainly on exploring the current evidence and providing a practical approach to assessment of 
extracapsular extension, seminal vesicle invasion and nodal disease. 
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Staging of prostate cancer 
 
The most widely used system for staging of prostate cancer is the tumour, nodes, and 
metastases (TNM) staging system developed by the American Joint Committee on Cancer 
(AJCC). The current version of the TNM staging of prostate cancer (8th edition) was 
implemented in January 2018 introducing grade groups and simplifying organ-confined 
disease to pathological stage pT2 and omitting pT2a–pT2c, however, this sub-classification is 
retained for clinical staging (Table 1).16 In addition, Cancer-group staging of prostate cancer 
(stage I–IV) is determined by TNM, PSA levels at diagnosis, and histologic Grade Groups.17  
Locally confined disease (T1–T2) is further divided into stage T1a and T1b tumours 
which are not apparent clinically and are found incidentally, typically at transurethral resection. 
From the radiological standpoint, the more relevant categories are stage T1c and T2 (a–c) as 
histologically they both represent a biopsy proven carcinoma albeit with an important 
difference: T1c cancer is by definition not visualised at MRI. This is relevant to active 
surveillance studies (AS) cohorts, with the term “non-visible lesion” (T1c) being introduced, 
based on the predictive nature of this feature, with a significantly increased progression free 
survival for non-visible lesions when compared with the MRI-visible lesions (T2).18 
Locally advanced prostate cancer carries a worse prognosis that organ-confined 
disease. T3a disease describes extraprostatic extension, T3b seminal vesicle invasion, and T4 
disease direct invasion of adjacent organs/structures (Table 1). In clinical practice those 
undergoing prostate mpMRI will have at least one sequence where the field of view covers the 
pelvis to the level of aortic bifurcation19 in order to evaluate the common iliac and bifurcation 
nodes (M1a) and from which partial M staging of the bony pelvis (M1b) can be performed. 
 
MR imaging 
 
MRI scanners 
The Prostate Imaging-Reporting and Data System (PI-RADS) guidelines19 are aimed at 
standardizing MRI acquisition and interpretation and recommend MRI to be performed at 3T 
in order to increase signal-to-noise ratio (SNR) and spatial resolution, and decrease acquisition 
times.20, 21 If acquisition protocols are optimized and contemporary technology is employed, 
then 1.5T scanners are also able to provide sufficient diagnostic performance. 1.5T scanning 
may also be preferential when a patient has an implant non-compatible at higher field strengths, 
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or with bilateral hip replacements in order to minimise artefact.22, 23 The routine use of an 
endorectal coil (ERC) is no longer recommended.19 3T scanners or contemporary 1.5T scanners 
can provide sufficient imaging quality and although ERC increases SNR bring disadvantages, 
including deformation of the gland contour, near field coil flare, increased cost and time of 
examination as well as higher patient discomfort.19,21  
 
MRI protocol 
Standard prostate MRI protocols should incorporate anatomical T1W and T2W imaging in 
combination with the two functional sequences of diffusion weighted imaging (DWI) and 
dynamic contrast enhanced imaging (DCE).24 A set of minimal technical parameters for each 
of these sequences is outlined in Table 225, although institutions are encouraged to optimize 
imaging protocols based on their own equipment, capacity and expertise. It is mandatory for 
axial T2W, DWI and DCE to be acquired in the same location, angle, slice thickness and gap 
to allow for synchronous scrolling through the images and direct evaluation of suspicious 
findings between the sequences. Axial T1WI is essential to assess post-biopsy haemorrhage, 
and is typically employed as the sequence to cover the pelvis to the aortic bifurcation to enable 
bone and nodal assessment.  
T2W imaging is the key sequence for local T-staging of the prostate. The high in-plane 
spatial resolution allows for accurate evaluation of extracapsular extension, neurovascular 
bundle assessment and seminal vesicle invasion. Fast-spin-echo (FSE) or turbo-spin-echo 
(TSE) imaging should be obtained in the axial plane and in least one additional orthogonal 
plane (sagittal or coronal) with the highest quality possible and thin slices at 3 mm with no 
gap.25 3D T2 weighted imaging with isotropic voxels and slice thickness at 1 mm may be 
obtained, with evidence suggesting utility for assessment of extraprostatic extension26 and for 
nodal and bone staging when combined with DWI of the entire pelvis (b-values 0–
1000s/mm2).27 
 
Limitations 
Motion artefact. Bowel peristalsis is a well-known cause of motion artefact in abdominal 
imaging, but the relatively low position of the prostate, remote from small bowel combined 
with limited evidence prior to PIRADS version 2 means that anti–spasmodic agents are not 
recommended in current guidelines. However, recent studies have shown use of anti-peristaltic 
agents significantly improves image quality of T2W imaging28, 29 with better depiction of 
anatomical details (e.g. prostatic capsule and neurovascular bundles) as well as reducing non-
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diagnostic MRI to < 1%.29 Routine use of antiperistaltic agents (recommended dose 20 mg 
HBB i.v. or 1 mg glucagon) prior to prostate mpMRI may therefore be beneficial for 
optimisation of T2W image quality, a key sequence of mpMRI for local staging.30 The risk of 
side-effects with these agents is low and these are usually minor and self-limiting.31  
 
T-staging  
 
T3a disease 
Extension of the tumour into the periprostatic fat is defined as T3a disease, termed 
extracapsular extension (ECE). Of note, however, in a strict sense the prostate lacks a true 
capsule as an anatomic structure that encloses the gland but has rather an outer fibromuscular 
layer which is inseparable component of the prostatic stroma.32, 33 T3a disease also incorporates 
invasion into the neurovascular bundle, internal sphincter and bladder neck. 1 
Histopathologically, extracapsular extension (ECE) is sub-classified into focal and established 
with the latter carrying a worse prognosis.34 However, there is currently no clear consensus on 
the exact definitions of these, which can vary from a few glands beyond the capsule to cancer 
extending up to 0.5 mm radially from the capsule.1 In addition,  focal ECE cannot be detected 
by MRI due to inherent resolution limits.35  
Extracapsular extension has traditionally been evaluated by clinical criteria and 
nomograms such as Partin tables, which are based on PSA, DRE and Gleason score at biopsy.36 
However, nomograms represent a patient level risk score alone, have been shown to be inferior 
to MRI11, 37, and unlike MRI offer no information on location and extent of ECE. A meta-
analysis by de Rooij et al. in 2016 showed MRI to have a high specificity of 91% but only 
moderate sensitivity at 57% in diagnosing ECE. Of note, this analysis included studies with 
both uni- and multi-parametric protocols at both 1.5T and 3T, and sub-analysis of 3T studies 
improved overall performance with specificity 86% and sensitivity 68%.38 The main reasons 
for improvement being higher spatial resolution at 3T and improved lesion identification with 
a multiparametric approach, allowing interrogation of the capsule and neurovascular bundle in 
the adjacent region (Figure 2).39 
Several approaches have been proposed and explored in order to increase diagnostic 
accuracy for the evaluation of ECE. Prostate imaging-reporting and data system (PI-RADS) 
guidelines recommends various morphologic criteria (Table 3).19 These have been evaluated 
and demonstrated sensitivity and specificity between 60%–81% and 75%–78%, respectively, 
and showed moderate inter-reader agreement (K = 0.45) for the prediction of T3a disease.40,41 
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In addition, the length of tumour contact with the capsule at MRI (Figure 3) has also 
been shown to be a strong predictor of ECE35,42,43 with good to excellent inter-reader 
agreement26,35 (Figure 3).26,35 However, a reliable threshold is yet to be established, with 
reported rates varying from 6–20 mm, the PI-RADS v2 guidelines recommend an arbitrary 
threshold of 10 mm19, which pre-dates many of these studies. The reason for variability is likely 
multifactorial with different methodology employed and variations in scanner strength, vendor 
and protocols. For instance, Rosenkrantz et al. measured the length in a linear rather than 
curvilinear fashion which likely explains their lower reported threshold of 6 mm.35 In addition, 
a more recent study suggests that thresholds differ between low- (Grade Group 1–2) and high-
grade (Grade Group 3–5) cancers, with the former having a positive predictive values (PPV) 
of 90.4% for ECE at 12.5 mm and the optimal cut-off for the latter being 5 mm.26 This finding 
was further confirmed by Matsuoka et al. who reported significantly increased upstaging in 
low- versus high-grade cancers when the same threshold (10 mm) was applied.44 Given that 
lower apparent diffusion coefficient (ADC) values in prostate cancer correlate with higher 
Gleason score45,46, this could potentially be exploited as an adjunct for more accurate diagnosis 
of T3a disease prior to biopsy results. To date however, there have been mixed results when 
applying ADC values for stage assessment, which may relate to difficulties in applying uniform 
quantitative values.39,47-50 
Another potential approach to improve sensitivity is utilisation of an isovolumetric 3D 
T2 imaging sequence to acquire thinner slices with less partial voluming and reformatting of 
isotropic images in multiple planes. Studies using 3D-T2 sequence have reported encouraging 
results with sensitivity and specificity ranging from 58.3%–84% and 73.1%–89%, 
respectively.44,51-53 In addition, Caglic et al. proposed a new criterion of 3D Contact which 
significantly improved detection of ECE (sensitivity, specificity: 73.7% and 87.8%) when 
compared to the length of capsular contact measured on conventional T2 imaging in axial plane 
(sensitivity, specificity: 59.6%, 87.8%).26 This approach exploited the reduced partial 
voluming due to thinner slices (Figure 4) and reconstruction of images in multiple planes in 
order to measure the more representative a truer length of capsular contact. Although not 
supported by work of Jäderling et al. using 3D-T2 reconstructions, it should be noted that their 
analysis was based on morphological criteria and not on quantifying capsular contact.54  
Although diagnostic accuracy for early ECE is improving, sensitivity remains relatively 
poor, and it should be noted that these results come from experienced centres, utilizing modern 
equipment and optimised protocols. As a result, equivocal MRI findings should not change the 
planned treatment course, but rather ensure discussion between radiologists and urologists at 
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multidisciplinary meetings on a case-by-case basis. Practical advice would be to flag 
indeterminate features of ECE, to allow wider surgical margins to be taken in the corresponding 
region.10 Furthermore, reporting the exact location of T3a disease is important, as clear margins 
are harder to obtain at the apex whereas tumours remote from the neurovascular bundle (NVB) 
such as in the anterior location will allow nerve sparing surgery and reduce resultant morbidity 
from urinary incontinence or erectile dysfunction. 
 
T3b disease 
T3b disease is defined as involvement of one or both seminal vesicles (SV) by prostate cancer, 
with the prevalence of SV invasion in surgical series being reported at 4–23%.55,56 Patients 
with T3b disease carry an increased risk of lymph node involvement, local recurrence and 
distant metastases57, making preoperative identification of SV involvement an important factor 
for prognosis and treatment planning. Patients with T3b disease are typically not offered radical 
prostatectomy or brachytherapy unless as part of a multimodal approach, and are usually 
offered external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT).  
MRI has been shown to outperform clinical risk assessment tools such as Kattan 
nomogram and Partin tables in predicting SV involvement13,58, with meta-analyses showing 
moderate sensitivity of 73%  and specificity of 95% for multiparametric MRI studies at 3T.38 
Recent work by Grivas et al. including 527 patients at 3T mpMRI achieved similar results with 
sensitivity, specificity, PPV and negative predictive values (NPV) at 75.9%, 94.7%, 62% and 
97%, respectively.59 
Histopathologically, SV invasion is defined as prostate cancer penetrating the SV 
muscular wall, with tumour involving the extraprostatic portion of the vesicles rather than the 
intraprostatic ejaculatory ducts.57 Three routes of invasion have been described, Type I: direct 
spread via the ejaculatory duct complex (Figure 5), Type II: extracapsular spread of disease 
with invasion via the outer seminal vesicle wall and type III: metastatic involvement from a 
remote intraprostatic lesion (Figure 6). The first two types individually or in combination 
account for more than 95% of cases, with type III spread being extremely rare.60, 61 
Seminal vesicles are best evaluated on T2W imaging in combination with functional 
imaging. Coronal or sagittal reformats are especially useful in demonstrating the type of spread. 
In Type I invasion, invasion via the erectile dysfunction (ED) causes SV expansion with a low 
signal intraluminal mass and may cause diffuse or focal wall thickening. In Type II 
involvement, there is obliteration of the angle between the base of the prostate and SV.60 In 
addition, in 2009 Jung et al. proposed a novel six-tier classification system for SV invasion 
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based on morphological appearance of SV on T2W imaging (Class 0 = normal SV appearance, 
Class 5 = apparent mass lesion with destructive architecture) showing sensitivity and 
specificity of 71.4 and 96.6%, respectively.62 More recent work incorporating functional 
sequences has further increased accuracy, with DWI proving to be of more incremental value 
than DCE.56,63 
There are known pitfalls to be aware of when assessing for SV involvement, such as 
diffuse wall thickening due to SV atrophy or asymmetry. In addition, there can be large 
variation with a mean right - left asymmetry of 20% and surgical series suggesting SV length 
between sides can vary up to 9-fold.64 Post-biopsy haemorrhage can mimic the low T2 signal 
of prostate cancer and review of T1W imaging for high signal within the SV is therefore 
essential. Another important mimic of prostate cancer is amyloidosis which exhibits low T2 
signal but does not show diffusion restriction (Figure 7). In cases with equivocal SV findings 
on prebiopsy MRI, patients can undergo subsequent targeted biopsy in order to correctly stage 
the disease (Figure 7).65  
Although PI-RADS v2 does not recommend abstinence from ejaculation prior to 
prostate mpMRI19, some centres require patients to refrain from ejaculation prior to imaging in 
order to achieve maximal distension. Recent studies suggest 72 hours abstinence as the 
recommended interval to achieve maximal seminal vesicle distension.66-69 This may be 
beneficial in evaluation of seminal vesicle invasion but further prospective studies including 
patients with prostate cancer are required to determine the effect on local staging accuracy. 
 
N-Staging 
 
EAU guidelines recommend N-staging should be performed on prebiopsy MRI in patients from 
all risk groups.1 This is in line with PI-RADS v2 guidelines which recommend that the prostate 
MRI protocol, which is primarily aimed at evaluating gland-confined and locally advanced 
disease, should also incorporate an additional sequence for the purpose of pelvic nodal staging 
from the level of aortic bifurcation.24 PCa spreads primarily to four pelvic nodal stations, 
considered regional nodes: the obturator, internal and external iliac and presacral LNs. 
Involvement of any regional node is classified as N1 stage, whilst involvement of non-regional 
stations (paraaortic or paracaval LNs) represents M1a disease.17,70 Nodal mapping studies have 
shown that approximately 75% of pelvic nodal metastases are distributed between the obturator 
fossa, internal and external iliac chain and the remaining 25% between the presacral, common 
iliac or aortic bifurcation group.71,72 
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MRI has traditionally relied on size and morphological criteria in LN assessment 
including an enlarged size (> 8 mm), loss of fatty hilum, rounded shape, low T2W signal 
similar to primary tumour, or an irregular border. This is of limited diagnostic accuracy mainly 
due to low sensitivity, with a meta-analysis from 2008 incorporating anatomical imaging 
studies alone (T2W and T1W) reporting a sensitivity of only 39% (specificity 82%).73 Size 
criteria in isolation is unhelpful, with a recent study showing the majority (68%) of metastatic 
nodes to have a short axis diameter < 5 mm.27 More recent studies have tried to establish 
whether an ADC threshold can be applied for discrimination of benign from malignant 
LNs.27,74-78 Although malignant LNs typically exhibit lower ADC values, there is significant 
overlap between normal and pathological LNs as well as large variation in the reported 
thresholds, limiting the value of quantitative ADC measures at an individual patient level.79 
Reasons for poor discrimination include micro metastasis being unlikely to lower the overall 
ADC value of a node, whilst some benign conditions (lipomatosis, sinus histiocytosis, and 
follicular hyperplasia)27 as well as inflammation (sarcoidosis and catch scratch disease) can 
also result in restricted diffusion within LNs.80,81 In addition, reproducibility of ADC 
measurements in small structures such as LNs may be insufficient and differences in 
acquisition protocols between centres further inhibits establishment of an absolute threshold.82-
85 Consequently, some studies have focused on qualitative assessment of DWI using high b-
value imaging in combination with anatomical T2W and reported improved performance with 
sensitivities of 55–73% and specificities of 86–90%.27,86 Normal LNs have an inherent 
relatively long T2 relaxation time and will therefore appear as high signal intensity structures 
on high b-value imaging (Figure 8), which is especially useful in depicting LNs as a ''nodal 
map'' when these do not meet size criteria. Detected nodes should then be carefully evaluated 
on T2W imaging in order to avoid false positive results due to structures which also appear 
bright on high b-value DWI (bowel mucosa, vessels, nerves)87 and to assess morphological 
features of malignancy. 
Current diagnostic performance of MRI in nodal staging is sub-optimal, thus ePLND 
remains the gold standard. Due to the limited sensitivity (high false negative rate) of MRI, 
negative findings should not deter surgeons from performing lymphadenectomy in patients 
with a high clinical risk for LN involvement. Conversely, the specificity of MRI is high (low 
false positive rate) and LNs considered to be suspicious at MRI warrant resection. 
Further work and development of imaging techniques with a high diagnostic 
performance is needed in order to more efficiently and less invasively identify patients with 
metastatic LNs. Initial clinical trials with prostate specific membrane antigen (68Ga-PSMA) 
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PET-MRI have shown promising results for detection of LN metastases88,89, resulting in change 
of treatment (either to systemic treatment or active surveillance) in approximately one third of 
patients.90 MR lymphangiography (MRL) with ultra-small superparamagnetic iron oxide 
(USPIO) has also demonstrated encouraging results with studies reporting sensitivity of 65–
100% and specificity of 93–100% on a per patient basis.91-93 However, USPIO is currently not 
licenced for general clinical use, with only the Netherlands producing it (commercially known 
as Combidex) and licensing it mainly for the research purposes in patients with PCa.94 
 
M-Staging 
 
EAU guidelines recommend staging for metastatic disease (M1a–M1c) in patients with 
unfavourable intermediate (International Society of Urological Pathology [ISUP] grade group 
3) or high-risk (ISUP grade group 4–5) disease.1 Current guidelines recommend evaluation of 
non-regional LNs and visceral metastases (M1a and M1c disease, respectively) by CT 
abdomen/pelvis imaging, combined with bone scintigraphy (BS) for evaluation of bone 
metastases (M1b disease) (Figure 9).95 
Several studies have shown MRI (either whole-body MRI or axial skeleton only MRI) 
to significantly outperform BS for assessment of M1b disease, with a thorough meta-analysis 
from 2014 reporting MRI sensitivity and specificity to be 97% and 95% compared to BS at 
79% and 82%, respectively.96 MRI is not incorporated into current guidelines mainly due to its 
limited availability and lower cost effectiveness.96 However, over the last decade whole body 
MRI (WB-MRI) has been gradually gaining attention due to its ability to detect bone marrow 
infiltration by malignant cells before bone remodelling occurs and therefore becomes visible 
on BS.97 The METastasis Reporting and Data System for Prostate (MET-RADS-P) is aimed at 
practical guidance for acquisition, interpretation, and reporting of WB-MRI in advanced 
prostate cancer.98 The recommended protocol consists of a combination of anatomical and 
functional sequences (T1W, short tau inversion recovery [STIR] or fat suppressed T2W and 
DW imaging). Bone metastases appear as low signal on T1W imaging, bright on STIR or fat 
suppressed T2W and with restricted diffusion. Beside bone assessment, WB-MRI can also 
provide N-staging and assess for involvement of visceral organs.99,100 Whilst the diagnostic 
potential of WBMRI is promising, there are barriers to widespread adoption, including 
additional coils required, increased scanning time, the need for sub-specialised knowledge, and 
increased reporting time. A recent study from 2018 by Larbi et al. has shown a possible means 
of overcoming some of these disadvantages by demonstrating that the combination of either 
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T1-DWI or T1-STIR is non-inferior to a full protocol (Figure 9), whilst at the same time 
showing good interobserver agreement.101  
 
 
Conclusions 
 
MpMRI is the recommended modality for the local staging of prostate cancer. It has shown 
superior performance compared to traditional staging based on clinical nomograms, and 
provides additional information on the site and extent of disease. T2W-weighted imaging 
remains the cornerstone for ECE and SV invasion assessment, however, improved accuracy 
can be achieved by scanning on 3T devices with the incorporation of diffusion weighted and 
dynamic contrast enhanced imaging. Whilst its role in nodal and bone staging outside academic 
centres is currently limited, there are emerging “next generation” imaging modalities including 
68Ga-PSMA-PET/MRI and whole-body MRI offer potential to become the future standard of 
care for evaluation, having shown superior results for distal staging in comparison to the 
traditional work-up with bone scintigraphy and body CT. Despite the advantages of mpMRI 
there remain limitations which should be known to radiologists and other members of the 
multidisciplinary team in order to jointly decide on the best treatment options for prostate 
cancer patients on an individual basis.  
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TABLES 
 
TABLE 1. Summary of TNM guidelines for the staging of prostate cancer 
Category Definition 
Tumour  
Tx Primary tumour cannot be assessed (e.g. CT study, severe artefacts on MRI) 
T1a–T1b  Tumour incidental histologic finding 
T1c Tumour identified by needle biopsy but not visible by imaging 
T2 Organ confined disease 
T2a The tumour involves up to one half of 1 side of the prostate 
T2b The tumour involves more than one half of 1 side of the prostate 
T2c The tumour involves both sides of the prostate 
T3 Extraprostatic extension 
T3a Extraprostatic extension (unilateral or bilateral) or microscopic invasion of 
the bladder neck 
T3b Tumour invades seminal vesicle(s) 
T4 Tumour invades adjacent structures other than seminal vesicles, such as 
external sphincter, rectum, bladder, levator muscles, and/or pelvic wall 
Node  
Nx Regional lymph nodes were not assessed 
N0 No positive regional lymph nodes 
N1 Metastases in regional lymph node(s) 
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Metastasis  
Mx M staging not assessed (e.g. MRI with pelvic only coverage) 
M0 No distant metastasis 
M1 Distant metastasis 
M1a Nonregional lymph node(s) 
M1b Bones 
M1c Other site(s) with or without bone disease 
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TABLE 2. PI-RADS v2.1 recommended MR imaging protocols  
Imaging sequence Technical parameters 
T2 imaging Axial plane and a minimum of one additional orthogonal plane (either 
sagittal or coronal) 
Straight axial plane to the patient or to the long axis of the prostate 
 FOV: 12-20 cm to image the entire prostate gland and seminal vesicles 
  
 Section thickens/gap: 3 mm/0 mm 
 In-plane resolution: ≤0.7 mm (phase) x ≤0.4 mm (frequency) 
DW imaging Axial plane (same locations as for T2WI) 
 Free-breathing spin echo EPI sequence combined with spectral fat  
saturation is recommended 
 Section thickness/gap: 3 mm/0 mm 
 TE: ≤90 ms; TR: >3000 ms   
 FOV: 16-22 cm   
 In plane dimension: ≤2.5 mm phase and frequency   
 ADC map calculation: low b-value should be set at 0 – 100 s/mm2, 
high b-value should be <1000 s/mm2  
 “High b-value”: b-value of ≥ 1400 sec/mm2; it can be acquired by scanning or 
calculated 
DCE Axial plane (same locations as for T2WI) 
 Fat suppression and/or subtraction is recommended   
 2D or 3D T1 GRE sequence (preferred) 
 Section thickness/gap: 3 mm/0 mm 
 Injection rate: 2-3 ml/s 
 TR/TE: <100 ms/ <5 ms   
 In-plane dimension: ≤2mm X ≤2mm  
 Temporal resolution: ≤15 s   
 Total observation: >2min 
2D = two-dimensional; 3D = three-dimensional; ADC = apparent diffusion coefficient; EPI = 
echo planar imaging; DW = diffusion weighted; FOV = field of view; GRE = gradient echo 
T2W = T2 weighted; TE = echo time; TR = repetition time 
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TABLE 3. PI-RADS v2 criteria for predicting extraprostatic extension  
Capsular abutment 
Capsular irregularity, spiculation or retraction 
Neurovascular bundle asymmetry or thickening 
Obliteration of the rectoprostatic angle 
Tumour-capsular contact > 10 mm 
Bulge or loss of capsule 
Measurable extracapsular disease 
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FIGURES 
 
 
FIGURE 1. 65-yr-old man with PSA 19.5 ng/ml. Invasion of the periprostatic fat and 
neurovascular bundle (NVB) infiltration at the left midgland consistent with T3a disease. 
Biopsy showed Gleason score (GS) 4 + 4 = 8. Radical retropubic prostatectomy (RRP) 
confirmed GS 4 + 4 = 8 and showed established T3a disease with a clear surgical margin (at 
least 1 mm).  
 
 
 
FIGURE 2. 77-yr-old man with PSA 38.2 ng/ml. A: T2 weighted (T2W) imaging; B: diffusion 
weighted (DW) imaging: C: apparent diffusion coefficient (ADC) map. T3a at the right mid 
gland with bulging and asymmetrical thickening of the right neurovascular bundle (arrow). 
Gleason score (GS) = 9 with extracapsular extension and clear surgical margins was confirmed 
at radical prostatectomy. 
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FIGURE 3. 74-yr-old man with PSA 35.2 ng/ml. A: T2 weighted (T2W) imaging, B: diffusion 
weighted (DW) imaging, C: apparent diffusion coefficient (ADC) map. T3a at the right mid 
gland as suggested by a broad capsular contact at 19.4 mm. Biopsy showed Gleason score (GS) 
4  +4 = 8 disease. Patient underwent radiotherapy. 
 
 
FIGURE 4. 57-yr-old man with PSA 26 ng/ml. A: Axial T2 weighted imaging (T2WI) shows 
mid gland right peripheral zones (PZ) lesion (arrow) with capsular contact but no tumour 
extension beyond it. B: axial thin-sliced cube reformat suggests capsular breach and right 
neurovascular bundle involvement (arrow). Prostatectomy showed tumour in the right mid 
gland, Gleason score 4 + 5 = 9, with established extracapsular extension (ECE) (pT3a). 
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FIGURE 5. 65-yr-old-man with PSA = 15.3 ng/ml and Gleason score 4 + 4 = 8 at biopsy. 
Axial (A) and coronal (C) T2 weighted imaging (T2WI) and diffusion weighted imaging 
(DWI) (B). T3b involving both seminal vesicles via ejaculatory ducts, shown in the coronal 
plane (arrow). 
 
 
 
FIGURE 6. 67-yr-old man with raising PSA = 12.7 ng/ml. A (coronal) and B (axial) T2 
weighted (T2W) imaging shows index lesion in the left apex (*) and a low signal focus in the 
left seminal vesicle (arrow) with corresponding restricted diffusion on diffusion weighted 
imaging (DWI) (C; arrow) and apparent diffusion coefficient (ADC) map (D; arrow). 
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FIGURE 7. 55-yr-old-man with PSA 32 ng/ml. A: T2 weighted (T2W) imaging, B: T1 
weighted (T1W) imaging, C: diffusion weighted (DW) imaging, D: apparent diffusion 
coefficient (ADC) map. Low T2 signal in the right seminal vesicle is mimicking prostate cancer 
(D), however, there is no restricted diffusion. Biopsy of the right seminal vesicle showed 
amyloidosis which was confirmed at radical prostatectomy. Index tumour with Gleason score 
4 + 3 = 7 was in the left peripheral zone. 
 
 
FIGURE 8. 77-yr-old man with PSA = 38.2 ng/ml. Enlarged nodes bilaterally consistent with 
metastatic involvement on T2 weighted imaging (T2WI) (A), more conspicuous on diffusion 
weighted imaging (DWI) (B).  
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FIGURE 9. 61-yr-old man with PSA = 12.7 ng/ml. Bone metastasis (arrow) in the right sacrum 
shown as low signal on T1 weighted (T1W) imaging (A); more conspicuous as high signal on 
diffusion weighted imaging (DWI) (B).  
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OPTIMIZING PROSTATE MRI: PREPARE FOR SUCCESS 
 
ABSTRACT 
Multiparametric MRI (mpMRI) now plays an essential role in prostate cancer diagnosis and 
management. The increasing use of MRI before biopsy makes obtaining images of the highest 
quality vital. The European Society of Urogenital Radiology (ESUR) 2012 guidelines and 
subsequent prostate imaging and reporting data system (PI-RADS) version 2 recommendations 
in 2015 address the technical considerations for optimizing MRI acquisition. However, the 
quality of the multiparametric sequences employed depends not only on the hardware and 
software utilized and scanning parameters selected, but also on patient-related factors, for 
which current guidance is lacking. Patient preparation factors include bowel peristalsis, rectal 
distension, the presence of total hip replacement (THR), post-biopsy haemorrhage and 
abstinence from ejaculation. New evidence has been accrued since the release of PI-RADS v2, 
and this review aims to explore the key issues of patient preparation and their potential to 
further optimize the image quality of mpMRI. 
 
  
 94 
 
OPTIMIZACIJA MR PROSTATE: PRIPRAVI ZA USPEH 
IZVLEČEK 
Multiparametrična magnetna resonanca (mpMR) ima osrednjo vlogo pri diagnostiki raka 
prostate (RP). Vedno bolj se uveljavlja slikanje z mpMR že pred samo biopsijo prostate, zato 
je bistveno, da so pridobljene slike najvišje kakovosti. Prvotne smernice evropskega združenja 
za urogenitalno radiologijo (European Society of Urogenital Radiology, ESUR) iz leta 2012 in 
poznejša razčirjena priporočila za slikanje in interpretacijo MR slik prostate (Prostate Imaging-
Reporting and Data System, PI-RADS) iz leta 2015 obravnavajo tehnične vidike optimizacije 
slikanja z MR. Kakovost mpMR slik  seveda ni odvisna le od uporabljene strojne in programske 
opreme ter izbranih parametrov slikanja, temveč tudi od dejavnikov, povezanih z bolnikom, za 
katere trenutne smernice priporočil ne dajejo. Dejavniki, ki so odvisni od bolnika, vključujejo 
črevesno peristaltiko, razširjenost danke, prisotnost kolčnih protez, hematom po biopsiji in 
abstinenco od ejakulacije. Po letu 2015, ko so izšle PI-RADS smernice, so nove raziskave 
obravnavale ključna vprašanja priprave bolnikov in v tem preglednem članku smo kritično 
povzeli nove rezultate ter njihov potencial, kako dodatno optimizirati kvaliteto mpMR slik. 
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CONCLUSIONS  
 
We have showed in our thesis:  
 
 The use of 3D-T2W imaging significantly increases sensitivity and confidence in 
calling ECE over conventional 2D-T2W imaging, confirming our first hypothesis. In 
addition, unexpected results show the contact length threshold is significantly longer 
for LGG than HGG cancers. 
 
 The administration of HBB prior to MRI of prostate is significantly associated with 
improved image quality of T2W imaging and decreases both motion artefact and 
blurring. These findings support our second hypothesis.  
 
 Increased rectal distension has a significant negative effect on the image quality of DWI 
and increased artefact and blurring. These results confirm the third hypothesis.  
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ZAKLJUČKI 
 
Z doktorsko nalogo smo pokazali:  
 
 Uporaba 3D-T2W slikanja značilno zviša senzitivnost in zaupanje radiologa pri 
diagnosticiranju ECE v primerjavi z običajnim 2D-T2W slikanjem. S temi izsledki smo 
potrdili prvo hipotezo. Nepričakovani rezultati kažejo, da je prag dolžine kontakta 
tumorjev z nizkim gradusom značilno daljši, kot z visokim gradusom. 
 
 Administracija HBB pred MR slikanjem je značilno povezana z izboljšano kvaliteto 
T2W slik, ter značilno zmanjša artefakte zaradi premikanja in izboljša ostrino slike. Te 
ugotovitve potrjujejo drugo hipotezo.   
 
 Razširjenost danke ima značilno negativen vpliv na kvaliteto DWI slik in značilno 
poveča distorzijo in artefakte, s čimer smo potrdili tretjo hipotezo.  
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APPENDIX 1  
 
PROSTATE SCORING SHEET Image Quality 
       
 
 
Hospital #:      EXAMINATION DATE:  
 
 
Reader: 1 / 2  
 
 
Patient Age:   
 
 
 
[1] Image quality  
1 = poor, 2 = suboptimal, 3 = adequate, 4 = above average, 5 = excellent 
 
 
 T2WI b-1400 ADC 
Score    
 
 
[2] Image blur/motion artefact on T2WI 
 
Motion artefact [movement or ghosting]:     Yes / No 
Blur [sharpness of capsule / NVB / SV vs periprostatic fat]:  Yes / No 
 
 
[3] Distortion and artefact on DWI (combined b1000 & ADC) 
 
 1 2 3 4 
Distortion O O O O 
Artefact O O O O 
Distortion: 1 = none, 2 = <5mm T2 mismatch, 3 = ≥5 mm OR mild warping, 4 = significant 
warping Artefact: 1 = nil, 2 = mild, not or mildly impacting diagnosis, 3 = moderate artifact, 
moderately impacting diagnosis, 4 = marked artifact, nondiagnostic. 
 
 
[4] Rectal Loading: Score: 
 
1 = no stool/gas, 2 = minimal, 3 = small amount, 4 = moderate, 5 = large amount of stool/gas 
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APPENDIX 2 3D ECE PROSTATE STUDY 
  
 
1st READ (Conventional) 
 
Patient #:   
 
Examination Date: 
  
Reading Date: 
 
Reader:  
 
 
 
 
 
 
 
 
 
ECE Yes / No Base/Mid/Apex 
(B-M-A) 
Length of 
contact [mm] 
ECE - 
circle it 
Total score 
1      
2      
3      
 
*Image distortion: 1 = no distortion, 1 = no distortion, 2 = <5mm mismatch to T2, 3 = ≥5 mm mismatch to T2 or mild warping, 4 = significant warping of prostate outline 
	
ECE Criteria SCORE 
Capsular abutment 1 
Capsular irregularity/thickening/retraction 3 
Neurovascular bundle thickening 4 
Capsular bulge/Loss of capsule 4 
Measurable extracapsular disease 5 
LESION Sector Max.Diameter 
T2w [mm] 
Max.Diameter 
ADC [mm] 
ADC 
value  
 
Probability 
score 
Image 
distortion 
(1-2-3-4)* 
1       
2       
3       
 116 
 
APPENDIX 3 3D ECE PROSTATE STUDY 
 
2nd READ (3D CUBE) 
 
Patient #:  
 
Examination Date:  
  
Reading Date: 
 
Reader: TB    FG 
 
 
 
 
 
 
 
 
 
ECE Yes / No Base/Mid/Apex 
(B-M-A) 
Length of 
contact[mm] 
Max. Length of 
contact - 3D 
ECE - 
Circle it 
Total 
score 
1       
2       
3       
 
*Image distortion: 1 = no distortion, 1 = no distortion, 2 = <5mm mismatch to T2, 3 = ≥5 mm mismatch to T2 or mild warping, 4 = significant warping of prostate outline 
	
ECE Criteria SCORE 
Capsular abutment 1 
Capsular irregularity/thickening/retraction 3 
Neurovascular bundle thickening 4 
Capsular bulge/Loss of capsule 4 
Measurable extracapsular disease 5 
LESION Sector Max.Diameter 
T2w [mm] 
Max. 
Diameter 
3D [mm] 
 Probability 
score 
Image 
distortion 
(1-2-3-4)* 
1       
2       
3       
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